These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29105082)

  • 41. Human Papillomavirus Status and the Risk of Cerebrovascular Events Following Radiation Therapy for Head and Neck Cancer.
    Addison D; Seidelmann SB; Janjua SA; Emami H; Staziaki PV; Hallett TR; Szilveszter B; Lu MT; Cambria RP; Hoffmann U; Chan AW; Wirth LJ; Neilan TG
    J Am Heart Assoc; 2017 Aug; 6(9):. PubMed ID: 28855164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HPV Testing of Head and Neck Cancer in Clinical Practice.
    Robinson M
    Recent Results Cancer Res; 2017; 206():101-111. PubMed ID: 27699532
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modulation of therapeutic sensitivity by human papillomavirus.
    Swick AD; Chatterjee A; De Costa AM; Kimple RJ
    Radiother Oncol; 2015 Sep; 116(3):342-5. PubMed ID: 26364887
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of the efficacy of the 4 tests (p16 immunochemistry, polymerase chain reaction, DNA, and RNA in situ hybridization) to evaluate a human papillomavirus infection in head and neck cancers: a cohort of 348 French squamous cell carcinomas.
    Augustin J; Outh-Gauer S; Mandavit M; Gasne C; Grard O; Denize T; Nervo M; Mirghani H; Laccourreye O; Bonfils P; Bruneval P; Veyer D; Péré H; Tartour E; Badoual C
    Hum Pathol; 2018 Aug; 78():63-71. PubMed ID: 29684499
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of human papillomavirus in the etiology of head and neck cancer.
    Tran N; Rose BR; O'Brien CJ
    Head Neck; 2007 Jan; 29(1):64-70. PubMed ID: 16823878
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cancer Immunology and HPV.
    Wollenberg B
    Recent Results Cancer Res; 2017; 206():243-248. PubMed ID: 27699544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HPV positive oropharyngeal cancer and treatment deintensification: how pertinent is it?
    Laskar SG; Swain M
    J Cancer Res Ther; 2015; 11(1):6-9. PubMed ID: 25879328
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
    Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human papillomavirus in head and neck cancer: molecular biology and clinicopathological correlations.
    Szentirmay Z; Pólus K; Tamás L; Szentkuti G; Kurcsics J; Csernák E; Tóth E; Kásler M
    Cancer Metastasis Rev; 2005 Jan; 24(1):19-34. PubMed ID: 15785870
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Head and neck second primary cancer rates in the human papillomavirus era: A population-based analysis.
    Diaz DA; Reis IM; Weed DT; Elsayyad N; Samuels M; Abramowitz MC
    Head Neck; 2016 Apr; 38 Suppl 1():E873-83. PubMed ID: 25966421
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent innovations in head and neck oncology: a report from the ICHNO.
    Stoeckli SJ; Broglie MA
    Expert Rev Anticancer Ther; 2013 May; 13(5):535-9. PubMed ID: 23617345
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human papillomavirus (HPV) in head and neck cancer.
    Syrjänen S
    J Clin Virol; 2005 Mar; 32 Suppl 1():S59-66. PubMed ID: 15753013
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The New Face of Head and Neck Cancer: The HPV Epidemic.
    Lewis A; Kang R; Levine A; Maghami E
    Oncology (Williston Park); 2015 Sep; 29(9):616-26. PubMed ID: 26384796
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.
    Gillison ML; Koch WM; Capone RB; Spafford M; Westra WH; Wu L; Zahurak ML; Daniel RW; Viglione M; Symer DE; Shah KV; Sidransky D
    J Natl Cancer Inst; 2000 May; 92(9):709-20. PubMed ID: 10793107
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HPV-avertable cancer risks in India: a pooled analysis of 9 observational studies.
    Patra J; Dikshit R; Bhatia M; Ramasundarahettige C; Jha P
    Int J Cancer; 2015 Jan; 136(2):491-2. PubMed ID: 24889780
    [No Abstract]   [Full Text] [Related]  

  • 56. Biological Features of Human Papillomavirus-related Head and Neck Cancers Contributing to Improved Response.
    Cleary C; Leeman JE; Higginson DS; Katabi N; Sherman E; Morris L; McBride S; Lee N; Riaz N
    Clin Oncol (R Coll Radiol); 2016 Jul; 28(7):467-74. PubMed ID: 27052795
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A new link between Fanconi anemia and human papillomavirus-associated malignancies.
    Lowy DR; Gillison ML
    J Natl Cancer Inst; 2003 Nov; 95(22):1648-50. PubMed ID: 14625250
    [No Abstract]   [Full Text] [Related]  

  • 58. Human papillomavirus and head and neck cancer: a growing concern.
    Gillespie MB; Smith J; Gibbs K; McRackan T; Rubinchik S; Day TA; Sutkowski N
    J S C Med Assoc; 2008 Dec; 104(8):247-51. PubMed ID: 19326612
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human Papillomavirus Testing in Head and Neck Carcinomas: ASCO Clinical Practice Guideline Endorsement Summary of the CAP Guideline.
    Fakhry C; Lacchetti C; Perez-Ordonez B
    J Oncol Pract; 2018 Oct; 14(10):613-617. PubMed ID: 30192693
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.